Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.50
Bid: 33.30
Ask: 33.50
Change: 0.20 (0.60%)
Spread: 0.20 (0.601%)
Open: 33.40
High: 33.60
Low: 32.50
Prev. Close: 33.30
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share options

16 Apr 2009 10:48

RNS Number : 6736Q
Alliance Pharma PLC
16 April 2009
 



For Immediate Release

16 April 2009

ALLIANCE PHARMA PLC

("the Company")

Share Options

Alliance Pharma plc (AIM: APH)the speciality pharmaceutical company, announces that on 14 April 2009 it awarded the following options over ordinary shares of the Company to certain Directors.

Name

Position

Number of options awarded

Exercise price per share

Date of vesting

Percentage of issued ordinary share capital

Tony Booley

Sales & Marketing Director

110,000

7.75p

14 April 2012

0.07%

Richard Wright

Finance Director

113,000

7.75p

14 April 2012

0.07%

For further information: 

Alliance Pharma plc
+ 44 (0) 1249 466966
John Dawson, Chief Executive
 
Richard Wright, Finance Director
 

www.alliancepharma.co.uk

 
 
 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
 
 
 
Numis Securities
+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
 
Corporate Broking: David Poutney
 

 

Notes to editors

About Alliance Pharma

Alliance Pharma, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, WiltshireUK. The company has a strong track record of acquiring the rights to established niche brands and owns, or licences, the rights to 35 branded pharmaceutical products and continues to explore opportunities to expand the range.

Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in the treatment of dermatological conditions, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers which service both hospital and retail pharmacies with their prescription requirements.

Alliance Pharma joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUNSKRKSRSARR
Date   Source Headline
29th Jul 20057:00 amRNSDistribution Agreement
13th Jul 200510:11 amRNSNotification of Shares
6th Jul 20057:00 amRNSPhase III Trials Approval
24th Jun 20057:00 amRNSNotice of Interests in Shares
21st Jun 200510:52 amRNSAGM Statement
17th May 20057:00 amRNSShare Purchase
16th May 200512:35 pmRNSDirector Share Dealing
12th May 20057:01 amRNSPreliminary Results
11th May 20059:55 amRNSShare Purchase
9th May 20057:00 amRNSCo-Promotion Agreement
26th Apr 20057:02 amRNSKey Management Appointments
30th Mar 20055:33 pmRNSHolding(s) in Company
16th Mar 20057:00 amRNSTrading Statement
28th Feb 200511:37 amRNSDirector Shareholding
11th Jan 20057:00 amRNSClinical Trial Commences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.